Benzinga·2026-01-14 17:26Group 1: Texas Instruments - Truist Securities analyst William Stein maintained a Hold rating on Texas Instruments and raised the price target from $175 to $195 [1] - Texas Instruments shares fell 0.3% to settle at $188.53 [4] Group 2: Crane Company - Crane Company announced the closure of its acquisition of Precision Sensors & Instrumentation from Baker Hughes [2] - Crane shares gained 0.9% to settle at $204.73 [4] Group 3: Catalyst Pharmaceuticals - Catalyst Pharmaceuticals reported better-than-expected third-quarter financial results, with earnings of 68 cents per share, beating the analyst consensus estimate of 33 cents per share [3] - The company raised its FY25 sales guidance above estimates, reporting quarterly sales of $148.392 million, surpassing the analyst consensus estimate of $136.802 million [3] - Catalyst Pharmaceuticals shares fell 3.8% to close at $22.35 [4]